distigmine has been researched along with Prostatic Hyperplasia in 2 studies
distigmine : A carbamate ester resulting from the formal condensation of both carboxy groups of hexane-1,6-diylbis(methylcarbamic acid) with the hydroxy group of 3-hydroxy-1-methylpyridinium.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Compared to patients on monotherapy, patients on combination therapy needed more TWOCs to void due to gradual increase in the dosage of distigmine bromide." | 1.38 | Cholinergic drugs for treatment of recurrent urinary retention in high surgical risk/elderly BPH patients. A pilot study. ( Skolarikos, A; Stamatiou, K; Tyritzis, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skolarikos, A | 1 |
| Tyritzis, S | 1 |
| Stamatiou, K | 1 |
| Suzuki, K | 1 |
| Miyamoto, T | 1 |
| Miyamoto, M | 1 |
| Hirata, K | 1 |
2 other studies available for distigmine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Cholinergic drugs for treatment of recurrent urinary retention in high surgical risk/elderly BPH patients. A pilot study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cholinergic Agents; Humans; Male; Prospective | 2012 |
Nocturnal hypersalivation caused by distigmine bromide in a patient with multiple system atrophy.
Topics: Cholinesterase Inhibitors; Diffusion Magnetic Resonance Imaging; Humans; Male; Middle Aged; Multiple | 2008 |